Lily Shahied Arruda, PhD, is a Medical Director on the U.S. Women’s Oncology team at Pfizer, Inc. She obtained her doctorate in molecular biology at Vanderbilt University upon completion of her bachelor's in chemistry at Furman University. She then pursued a post-doctoral fellowship at the Fox Chase Cancer Center in Philadelphia where her research focused on the design and testing of genetically engineered bispecific antibodies for the HER2 and CD16 receptors in breast cancer models. Since then, Dr. Arruda has spent the last 15 years building expertise in oncology in the pharmaceutical industry setting. She has held roles within both the R&D and medical affairs sectors which have allowed her to build and apply her medical knowledge across the oncology drug development process.
